Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rigel Pharmaceuticals Inc.

www.rigel.com

Latest From Rigel Pharmaceuticals Inc.

Roche’s Polivy Among Seven New Drugs On Track For EU-Wide Approval

Seven drugs, including two orphans and two generics, are on track to receive pan-EU approval.

Europe Approvals

EU: Rigel And Jazz Among Hopefuls At CHMP

Rigel Pharmaceuticals and Jazz Pharmaceuticals are among the companies that could find out this week whether their new drug applications at the European Medicines Agency are likely to be approved for marketing across the EU. The EMA's key scientific committee, the CHMP, will also consider applications from Roche and Novartis.

Europe BioPharmaceutical

UCB Pharma Among Latest Sponsors Up For CHMP Oral Explanations

A number of companies were due or potentially due to appear before the European Medicines Agency’s drug evaluation committee, the CHMP, this week to answer questions in person about their marketing applications.

Finance Watch: BioNTech, Vir Launch IPOs But Take US Offerings To Market At A Discount

BioNTech's $150m offering, after a prior large venture capital financing, gives it the third-largest market cap for a newly public drug developer in the US. Also, Innovent raises $300m in Hong Kong offering, Heron leads US follow-ons and Five Prime restructures to save $20m annually.
Financing StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Dermatology
  • Immune Disorders
  • Renal System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Rigel Pharmaceuticals Inc.
  • Senior Management
  • Raul R Rodriquez, Pres. & CEO
    Dean Schorno, EVP, CFO
    Wolfgang Dummer, MD, PhD, CMO
    Eldon C Mayer, III, EVP, Chief Commercial Officer
  • Contact Info
  • Rigel Pharmaceuticals Inc.
    Phone: (650) 624-1100
    1180 Veterans Blvd.
    S. San Francisco, CA 94080
    USA
UsernamePublicRestriction

Register